Research News and Research

RSS

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

TuBerculosis Vaccine Initiative (TBVI) recently received a $3million grant for a three year term from the Bill & Melinda Gates Foundation. This grant enables the nonprofit organization to strengthen its fundraising and communication activities in order to increase awareness and support for tuberculosis (TB) vaccine research and raise funds for the development of safer and more effective vaccines.

25 Aug 2009

Garden Of Life introduces dietary supplement capsule that minimizes varicose and spider veins

For years, millions of women tried everything from heavy leg make up to dark pantyhose to cover up unsightly varicose and spider veins. Now there's a better way to reduce the appearance of unwanted veins with Garden of Life's (www.gardenoflife.com) Lovely Legs(TM), the only dietary supplement backed by extensive human clinical studies and millions of happy European women.

25 Aug 2009

Study reveals that Americans lack confidence in healthcare reforms

Americans lack confidence that healthcare reform will deliver more affordable or better quality medical care, according to a survey released today by the Thomson Reuters.

25 Aug 2009

MEDRAD and USF sign research agreement to study FDG administration effect on the workflow for PET imaging procedures

...

25 Aug 2009

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

Today, Secretary of Health and Human Services Kathleen Sebelius announced her intent to appoint Helene Gayle, MD, MPH to serve as the Chair of the Presidential Advisory Council on HIV/AIDS. Secretary Sebelius made the announcement in Atlanta at the 2009 National HIV Prevention Conference.

25 Aug 2009

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

In order to reduce the Province's greenhouse gas emissions, the BC Bioenergy Strategy is calling for greatly increased production of renewable biofuels such as ethanol, from biomass grown in BC. Two new research projects, largely funded by Genome BC, will help to answer these questions and unlock the valuable green energy found within BC's forests.

25 Aug 2009

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that study results demonstrated that arimoclomol exhibited both statistically significant neuroprotective and neuroregenerative effects in brain cells of animals induced with stroke, offering important insights into this drug candidate’s mechanism of action.

25 Aug 2009

NanoBusiness 2009 conference to address nanotechnology advancements in various markets

The NanoBusiness Alliance, the world's leading nanotechnology trade association, today announced details of its expanded conference program for the 8th annual NanoBusiness 2009 conference and exhibition, which will held at McCormick Place in Chicago, IL, from September 8 – 10.

25 Aug 2009

CenterWatch senior edtior to deliver keynote address at KIKA’s U.S. User Group Meeting

KIKA Clinical Solutions announced that Sara Gambrill, Senior Editor of CenterWatch, will be a keynote speaker at KIKA’s U.S. User Group Meeting. KIKA is the leading provider of advanced EDC solutions for clinical trials, and creators of the Veracity Web-based platform for Clinical Asset Management. The User Group Meeting will take place October 21 and 22 in Boston.

25 Aug 2009

Dalai Lama to participate in The Mind and Life Institute's Washington D.C. conference

On Oct. 8-9, 2009, the Dalai Lama will participate in our Washington D.C. conference, Educating World Citizens for the 21st Century. The goal of this ML XIX conference is to explore the value of integrating emotional, intellectual and social learning into today's educational programs with the intention to promote education research into these areas.

25 Aug 2009

Cybex International re-brands its research division as Cybex Institute For Exercise Science

Cybex International, Inc., a leading manufacturer of premium exercise equipment for the commercial and consumer markets, announced today the re-branding of its research arm as the Cybex Institute for Exercise Science, with the continued mission of disseminating scientifically accurate information applicable to the disciplines of general fitness, sports performance and clinical medicine.

25 Aug 2009

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

Bavarian Nordic A/S (OMX: BAVA) announced today that the US authorities have initiated negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE(R) smallpox vaccine.

25 Aug 2009

OriGene Technologies releases recombinant proteins purified from HEK293 cells

OriGene Technologies, Inc. announces the release of 5,000 purified human proteins, representing the most comprehensive offering of human cell-produced human proteins.

25 Aug 2009

Combined therapy for acute leukemia shows promising results

Two of the most powerful approaches to cancer treatment -- a stem cell transplant and an immune system-stimulating vaccine -- appear to reinforce each other in patients with an aggressive, hard-to-control form of leukemia, Dana-Farber Cancer Institute scientists have found.

25 Aug 2009

Study reveals safety of ConvaTec's advanced antimicrobial dressing

ConvaTec, a world-leading provider of innovative medical technologies for community and hospital care, today announced new data showing that AQUACEL(R) Ag, the company's advanced antimicrobial dressing, is safe for use in an MRI environment.

25 Aug 2009

Portola Pharmaceuticals' investigational antiplatelet drug elinogrel featured at the ESC Congress 2009

Portola Pharmaceuticals, Inc. today announced two oral presentations at the European Society of Cardiology (ESC) Congress 2009 in Barcelona, Spain, that will feature its investigational antiplatelet drug elinogrel, a P2Y12 ADP receptor antagonist that is currently in Phase II clinical development with Novartis, Portola's development and commercialization partner.

25 Aug 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

A landmark report released today by the Lance Armstrong Foundation (LAF) estimates the total economic burden of new cancer cases at $305 billion in 2009. The findings are included in the report, "Breakaway: The Global Burden of Cancer - Challenges and Opportunities," released today in Dublin at the premiere LIVESTRONG Global Cancer Summit.

25 Aug 2009

Malaysian biotechnology industry expected to grow by revenue at an average rate of 15 percent per year

Malaysia's plans for its biotechnology sector remain ambitious even with the recent global meltdown. By 2020 the government envisages this sector will employ up to 160,000 people and will contribute to 5% of Malaysia's GDP.

25 Aug 2009

A new therapy for treating gastro-oesophageal reflux in babies

20% of parents seek medical help because of the frequent regurgitation (spitting up food) of their baby and the accompanying discomfort (crying). Reputed medical journal "Archives of Disease in Childhood" of the "British Medical Journal" group recently published the results of the clinical research project that began at the end of 2006 in the Children's gastroenterology department of the Brussels University Hospital.

25 Aug 2009

New RAND study finds that Prescription Benefit Program for Medicare recipients surpasses expectations

The program created to provide Medicare recipients with prescription drug benefits exceeded expectations during its first two years, extending pharmacy coverage to most seniors while reducing their overall spending on drugs, according to a new RAND Corporation study.

25 Aug 2009

Research News and Research

TuBerculosis Vaccine Initiative receives $3 million grant from Gates Foundation

Garden Of Life introduces dietary supplement capsule that minimizes varicose and spider veins

Study reveals that Americans lack confidence in healthcare reforms

MEDRAD and USF sign research agreement to study FDG administration effect on the workflow for PET imaging procedures

Health and Human Services Secretary to appoint Helene Gayle as the Chair of Presidential Advisory Council

Genome BC's research projects to determine efficient methods of liberating fermentable sugars from dead pine

Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke

NanoBusiness 2009 conference to address nanotechnology advancements in various markets

CenterWatch senior edtior to deliver keynote address at KIKA’s U.S. User Group Meeting

Dalai Lama to participate in The Mind and Life Institute's Washington D.C. conference

Cybex International re-brands its research division as Cybex Institute For Exercise Science

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

OriGene Technologies releases recombinant proteins purified from HEK293 cells

Combined therapy for acute leukemia shows promising results

Study reveals safety of ConvaTec's advanced antimicrobial dressing

Portola Pharmaceuticals' investigational antiplatelet drug elinogrel featured at the ESC Congress 2009

LAF report estimates the total economic burden of new cancer cases at $305 billion in 2009

Malaysian biotechnology industry expected to grow by revenue at an average rate of 15 percent per year

A new therapy for treating gastro-oesophageal reflux in babies

New RAND study finds that Prescription Benefit Program for Medicare recipients surpasses expectations

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News